Chemotherapy-induced neutropenia and febrile neutropenia in patients with gynecologic malignancy

od Hashiguchi, Yasunori, Kasai, Mari, Fukuda, Takeshi, Ichimura, Tomoyuki, Yasui, Tomoyo, Sumi, Toshiyuki
izdano v Anticancer Drugs (2015)

UCP2 expression may represent a predictive marker of neoadjuvant chemotherapy effectiveness for locally advanced uterine cervical cancer

od Imai, Kenji, Fukuda, Takeshi, Wada, Takuma, Kawanishi, Masaru, Tasaka, Reiko, Yasui, Tomoyo, Sumi, Toshiyuki
izdano v Oncol Lett (2017)

Metabolic and Morphologic Characteristics of Adipose Tissue Associated with the Growth of Malignant Tumors

od Ishiko, Osamu, Nishimura, Sadako, Yasui, Tomoyo, Sumi, Toshiyuki, Hirai, Kouzo, Honda, Ken‐ichi, Ogita, Sachio
izdano v Jpn J Cancer Res (1999)

Minimal deviation mucinous adenocarcinoma of the uterine cervix that proved difficult to differentiate from endometrial cancer: A case report

od NISHII, YUKO, FUKUDA, TAKESHI, IMAI, KENJI, YAMAUCHI, MAKOTO, HASHIGUCHI, YASUNORI, ICHIMURA, TOMOYUKI, YASUI, TOMOYO, SUMI, TOSHIYUKI
Izdano 2014

Sirtuin1 expression predicts the efficacy of neoadjuvant chemotherapy for locally advanced uterine cervical cancer

od TERAMAE, MASATOMO, FUKUDA, TAKESHI, WADA, TAKUMA, KAWANISHI, MASARU, IMAI, KENJI, YAMAUCHI, MAKOTO, YASUI, TOMOYO, SUMI, TOSHIYUKI
izdano v Mol Clin Oncol (2015)

Expression of epidermal growth factor-like domain 7 may be a predictive marker of the effect of neoadjuvant chemotherapy for locally advanced uterine cervical cancer

od Yamauchi, Makoto, Fukuda, Takeshi, Wada, Takuma, Kawanishi, Masaru, Imai, Kenji, Tasaka, Reiko, Yasui, Tomoyo, Sumi, Toshiyuki
izdano v Oncol Lett (2016)

TBX2 expression is associated with platinum-sensitivity of ovarian serous carcinoma

od Tasaka, Reiko, Fukuda, Takeshi, Shimomura, Masahiro, Inoue, Yuta, Wada, Takuma, Kawanishi, Masaru, Yasui, Tomoyo, Sumi, Toshiyuki
izdano v Oncol Lett (2018)

Expression of UCP2 is associated with sensitivity to platinum-based chemotherapy for ovarian serous carcinoma

od Kawanishi, Masaru, Fukuda, Takeshi, Shimomura, Masahiro, Inoue, Yuta, Wada, Takuma, Tasaka, Reiko, Yasui, Tomoyo, Sumi, Toshiyuki
izdano v Oncol Lett (2018)

Mitotic arrest deficiency 2 induces carcinogenesis in mucinous ovarian tumors

od NAKANO, YUSUKE, SUMI, TOSHIYUKI, MORISHITA, MASANARI, FUKUDA, TAKESHI, NOBEYAMA, HIROYUKI, YOSHIDA, HIROYUKI, MATSUMOTO, YOSHINARI, YASUI, TOMOYO, ISHIKO, OSAMU
Izdano 2012

Comparison of outcomes between squamous cell carcinoma and adenocarcinoma in patients with surgically treated stage I–II cervical cancer

od YAMAUCHI, MAKOTO, FUKUDA, TAKESHI, WADA, TAKUMA, KAWANISHI, MASARU, IMAI, KENJI, HASHIGUCHI, YASUNORI, ICHIMURA, TOMOYUKI, YASUI, TOMOYO, SUMI, TOSHIYUKI
Izdano 2014

Complete recovery from paraneoplastic anti-NMDAR encephalitis associated with a small ovarian teratoma following a laparoscopic salpingo-oophorectomy: A case report

od IMAI, KENJI, FUKUDA, TAKESHI, WADA, TAKUMA, KAWANISHI, MASARU, YAMAUCHI, MAKOTO, HASHIGUCHI, YASUNORI, ICHIMURA, TOMOYUKI, YASUI, TOMOYO, SUMI, TOSHIYUKI
izdano v Exp Ther Med (2015)

XPA expression is a predictive marker of the effectiveness of neoadjuvant chemotherapy for locally advanced uterine cervical cancer

od Wada, Takuma, Fukuda, Takeshi, Shimomura, Masahiro, Inoue, Yuta, Kawanishi, Masaru, Tasaka, Reiko, Yasui, Tomoyo, Ikeda, Kazuo, Sumi, Toshiyuki
izdano v Oncol Lett (2018)

PRMT1 expression predicts response to neoadjuvant chemotherapy for locally advanced uterine cervical cancer

od Shimomura, Masahiro, Fukuda, Takeshi, Awazu, Yuichiro, Nanno, Shigenori, Inoue, Yuta, Matsubara, Hiroaki, Yamauchi, Makoto, Yasui, Tomoyo, Sumi, Toshiyuki
izdano v Oncol Lett (2021)

PRMT1 expression predicts sensitivity to platinum-based chemotherapy in patients with ovarian serous carcinoma

od Matsubara, Hiroaki, Fukuda, Takeshi, Awazu, Yuichiro, Nanno, Shigenori, Shimomura, Masahiro, Inoue, Yuta, Yamauchi, Makoto, Yasui, Tomoyo, Sumi, Toshiyuki
izdano v Oncol Lett (2021)

Expression of mitotic-arrest deficiency 2 predicts the efficacy of neoadjuvant chemotherapy for locally advanced uterine cervical cancer

od MORISHITA, MASANARI, SUMI, TOSHIYUKI, NAKANO, YUSUKE, TERAMAE, MASATOMO, FUKUDA, TAKESHI, NOBEYAMA, HIROYUKI, YOSHIDA, HIROYUKI, MATSUMOTO, YOSHINARI, YASUI, TOMOYO, ISHIKO, OSAMU
Izdano 2012

Pegylated liposomal doxorubicin for platinum-resistant or refractory Müllerian carcinoma (epithelial ovarian carcinoma, primary carcinoma of Fallopian tube and peritoneal carcinoma...

od FUKUDA, TAKESHI, SUMI, TOSHIYUKI, TERAMAE, MASATOMO, NAKANO, YUSUKE, MORISHITA, MASANARI, TERADA, HIROYUKI, YOSHIDA, HIROYUKI, MATSUMOTO, YOSHINARI, YASUI, TOMOYO, ISHIKO, OSAMU
Izdano 2013

A retrospective clinical analysis of 5 cases of vaginal melanoma

od Tasaka, Reiko, Fukuda, Takeshi, Wada, Takuma, Kawanishi, Masaru, Imai, Kenji, Kasai, Mari, Hashiguchi, Yasunori, Ichimura, Tomoyuki, Yasui, Tomoyo, Sumi, Toshiyuki
izdano v Mol Clin Oncol (2017)

Extragastrointestinal stromal tumor originating from the vulva

od Fukuda, Takeshi, Sumi, Toshiyuki, Nakano, Yusuke, Morishita, Masanari, Nobeyama, Hiroyuki, Yoshida, Hiroyuki, Matsumoto, Yoshinari, Yasui, Tomoyo, Honda, Ken-ichi, Ishiko, Osamu
Izdano 2011

Pharmacokinetic analyses of carboplatin in a patient with cancer of the fallopian tubes undergoing hemodialysis: A case report

od Wada, Takuma, Fukuda, Takeshi, Kawanishi, Masaru, Tasaka, Reiko, Imai, Kenji, Yamauchi, Makoto, Kasai, Mari, Hashiguchi, Yasunori, Ichimura, Tomoyuki, Yasui, Tomoyo, Sumi, Toshiyuki
izdano v Biomed Rep (2016)

Age-related differences in prognosis and prognostic factors among patients with epithelial ovarian cancer

od Yoshikawa, Kenji, Fukuda, Takeshi, Uemura, Ryo, Matsubara, Hiroaki, Wada, Takuma, Kawanishi, Masaru, Tasaka, Reiko, Kasai, Mari, Hashiguchi, Yasunori, Ichimura, Tomoyuki, Yasui, Tomoyo, Sumi, Toshiyuki
izdano v Mol Clin Oncol (2018)